Circulating Tumor DNA as a Minimal Residual Disease Assessment and Recurrence Risk in Patients Undergoing Curative-Intent Resection with or without Adjuvant Chemotherapy in Colorectal Cancer: A Systematic Review and Meta-Analysis

医学 内科学 肿瘤科 结直肠癌 危险系数 荟萃分析 子群分析 阶段(地层学) 化疗 循环肿瘤DNA 佐剂 微小残留病 癌症 生物标志物 置信区间 化学 白血病 古生物学 生物 生物化学
作者
Anusha Chidharla,Eliot Rapoport,Kriti Agarwal,Samragnyi Madala,Brenda Linares,Weijing Sun,Sakti Chakrabarti,Anup Kasi
出处
期刊:International Journal of Molecular Sciences [Multidisciplinary Digital Publishing Institute]
卷期号:24 (12): 10230-10230 被引量:20
标识
DOI:10.3390/ijms241210230
摘要

Emerging data have suggested that circulating tumor DNA (ctDNA) can be a reliable biomarker for minimal residual disease (MRD) in CRC patients. Recent studies have shown that the ability to detect MRD using ctDNA assay after curative-intent surgery will change how to assess the recurrence risk and patient selection for adjuvant chemotherapy. We performed a meta-analysis of post-operative ctDNA in stage I–IV (oligometastatic) CRC patients after curative-intent resection. We included 23 studies representing 3568 patients with evaluable ctDNA in CRC patient post-curative-intent surgery. Data were extracted from each study to perform a meta-analysis using RevMan 5.4. software. Subsequent subgroup analysis was performed for stages I–III and oligometastatic stage IV CRC patients. Results showed that the pooled hazard ratio (HR) for recurrence-free survival (RFS) in post-surgical ctDNA-positive versus -negative patients in all stages was 7.27 (95% CI 5.49–9.62), p < 0.00001. Subgroup analysis revealed pooled HRs of 8.14 (95% CI 5.60–11.82) and 4.83 (95% CI 3.64–6.39) for stages I–III and IV CRC, respectively. The pooled HR for RFS in post-adjuvant chemotherapy ctDNA-positive versus -negative patients in all stages was 10.59 (95% CI 5.59–20.06), p < 0.00001. Circulating tumor DNA (ctDNA) analysis has revolutionized non-invasive cancer diagnostics and monitoring, with two primary forms of analysis emerging: tumor-informed techniques and tumor-agnostic or tumor-naive techniques. Tumor-informed methods involve the initial identification of somatic mutations in tumor tissue, followed by the targeted sequencing of plasma DNA using a personalized assay. In contrast, the tumor-agnostic approach performs ctDNA analysis without prior knowledge of the patient’s tumor tissue molecular profile. This review highlights the distinctive features and implications of each approach. Tumor-informed techniques enable the precise monitoring of known tumor-specific mutations, leveraging the sensitivity and specificity of ctDNA detection. Conversely, the tumor-agnostic approach allows for a broader genetic and epigenetic analysis, potentially revealing novel alterations and enhancing our understanding of tumor heterogeneity. Both approaches have significant implications for personalized medicine and improved patient outcomes in the field of oncology. The subgroup analysis based on the ctDNA method showed pooled HRs of 8.66 (95% CI 6.38–11.75) and 3.76 (95% CI 2.58–5.48) for tumor-informed and tumor-agnostic, respectively. Our analysis emphasizes that post-operative ctDNA is a strong prognostic marker of RFS. Based on our results, ctDNA can be a significant and independent predictor of RFS. This real-time assessment of treatment benefits using ctDNA can be used as a surrogate endpoint for the development of novel drugs in the adjuvant setting.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
珈蓝完成签到,获得积分10
1秒前
嘟嘟请让一让完成签到,获得积分10
2秒前
莫x莫完成签到 ,获得积分10
3秒前
bubble完成签到,获得积分10
4秒前
4秒前
万能图书馆应助sl采纳,获得10
4秒前
河丫应助sl采纳,获得10
4秒前
量子星尘发布了新的文献求助10
5秒前
科研人发布了新的文献求助10
5秒前
5秒前
魏莱关注了科研通微信公众号
6秒前
dd发布了新的文献求助10
7秒前
yifan92完成签到,获得积分10
8秒前
9秒前
灵巧的孤容完成签到,获得积分10
10秒前
袁翰将军发布了新的文献求助10
10秒前
a雪橙完成签到 ,获得积分10
12秒前
超帅的碱完成签到,获得积分10
12秒前
13秒前
陈大海完成签到,获得积分20
13秒前
LaTeXer给积极行天的求助进行了留言
13秒前
白斯特完成签到,获得积分10
14秒前
科研混子完成签到,获得积分10
14秒前
听雨完成签到 ,获得积分10
14秒前
jianglili完成签到 ,获得积分10
14秒前
思源应助王云骢采纳,获得10
15秒前
等待的航空完成签到 ,获得积分10
16秒前
顾矜应助乔安采纳,获得10
16秒前
雪ノ下詩乃完成签到,获得积分10
17秒前
神外之城发布了新的文献求助80
17秒前
科研人完成签到,获得积分10
19秒前
莫友安完成签到 ,获得积分10
19秒前
大个应助迅速曼冬采纳,获得10
20秒前
热心市民小红花应助阿湫采纳,获得10
21秒前
快乐战神没烦恼完成签到,获得积分10
21秒前
顾矜应助魏莱采纳,获得10
21秒前
SYLH应助Rollei采纳,获得10
21秒前
22秒前
dd完成签到,获得积分20
22秒前
高分求助中
【提示信息,请勿应助】关于scihub 10000
Les Mantodea de Guyane: Insecta, Polyneoptera [The Mantids of French Guiana] 3000
徐淮辽南地区新元古代叠层石及生物地层 3000
The Mother of All Tableaux: Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 3000
Global Eyelash Assessment scale (GEA) 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 550
Research on Disturbance Rejection Control Algorithm for Aerial Operation Robots 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 4038446
求助须知:如何正确求助?哪些是违规求助? 3576149
关于积分的说明 11374627
捐赠科研通 3305875
什么是DOI,文献DOI怎么找? 1819354
邀请新用户注册赠送积分活动 892680
科研通“疑难数据库(出版商)”最低求助积分说明 815048